Le Lézard
Classified in: Health
Subjects: NPT, SVY

Low-Dose Radiation Can Enhance Natural Barriers to Cancer, according to the Journal of American Physicians and Surgeons


TUCSON, Ariz., Dec. 14, 2017 /PRNewswire-USNewswire/ -- High-dose ionizing radiation is known to reduce the body's resistance to cancer, but low-dose radiation actually enhances natural defenses, writes Bobby R. Scott, Ph.D., in the winter issue of the Journal of American Physicians and Surgeons. This means that the widely believed statement that "there is no safe dose of radiation" is not true.

Scott, a scientist emeritus at the Lovelace Respiratory Research Institute in Albuquerque, N.M., points out in this review that natural background radiation is estimated to have been five-fold higher in earlier eras, and mammals likely survived because of enhanced natural cancer barriers.

All the cells in the body are constantly subjected to damage from reactive oxygen species generated through normal metabolic processes. Radiation injury results from the same mechanism. Without sophisticated molecular defense mechanisms, the cell would soon die from unrepaired damage to DNA, enzymes, and other cellular components.

One defense is "antioxidant" enzymes that deactivate reactive oxygen species. As revealed in animal studies, levels of these enzymes increase in response to whole-body exposure to low and moderate doses of ionizing radiation.

The most serious type of damage is double-strand breaks in DNA. These increase linearly with dose, and this relationship led to the false belief that cancer induction is also a linear no-threshold function of radiation dose, i.e. that any dose can increase the risk of cancer. However, DNA double-strand break repair is activated by low radiation doses, producing a protective natural barrier to mutation-related harm.

This "adaptive response" at low doses also reduces the frequency of spontaneous mutations, unlike high doses, which increase the frequency. An entity that causes harm at high levels but protection at low levels is said to have a hormetic dose-response relationship, Scott explains.

Scott also reviews experimental evidence for additional protective effects induced by low-level regulation, including epigenetic regulation of gene expression, cellular senescence, selective removal of aberrant cells, tissue-level interactions, suppression of cancer-facilitating inflammation, and enhancement of anti-cancer immunity.

Together, the indicated protective effects (cancer barriers), when activated by low-dose ionizing radiation, can reduce the frequency of cancer to well below the background level.

Scott concludes that low doses of ionizing radiation are more likely to be beneficial rather than harmful.

The Journal of American Physicians and Surgeons is published by the Association of American Physicians and Surgeons (AAPS), a national organization representing physicians in all specialties since 1943.

 

SOURCE Association of American Physicians and Surgeons (AAPS)


These press releases may also interest you

at 20:00
SysInformation Healthcare Services, LLC ("SysInformation"), d/b/a EqualizeRCM and 1st Credentialing, is providing notice of a recent data security event that may affect the security of information related to certain individuals. SysInformation is...

at 19:32
Scottie Resources Corp. ("Scottie" or the "Company") announces that it has granted 7,400,000 options to acquire common shares to certain directors, officers, and consultants to the Company. The options are exercisable at a price of $0.195 per...

at 19:31
DaVita Inc. , announced today that it will hold its quarterly conference call to discuss first quarter results on Thursday, May 2, 2024, at 5:00 p.m. Eastern Time. The company plans to release its results after market close the same day. This call is...

at 18:05
As part of its ongoing mission to meet the growing need for emergency services in metro Atlanta, Grady Health System will build a freestanding emergency department in south Fulton County. This freestanding emergency department, built in partnership...

at 18:00
Digicann Ventures Ltd. ("Digicann" or the "Company") , a company focused on opportunities within and outside of the cannabis industry, announces that it has entered into an agreement with holders of the Company's 10.00% Senior Unsecured Convertible...

at 18:00
Beauty-Stem, a subsidiary of Power-Stem Biomedical, has been at the forefront of stem cell research and development since its parent company's inception in Taiwan back in 2005. With...



News published on and distributed by: